Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor(ACEI) captopril on ischemic myocardium.
目的评价血管紧张素转换酶抑制剂（ACEI）卡托普利对缺血心肌的药理作用。
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
Purpose to investigate the anti-inflammatory effect of angiotensin-converting enzyme inhibitor captopril on the brain against ischemia-reperfusion injury and explore its mechanism of action.
目的观察血管紧张素转化酶抑制药卡托普利对大鼠局灶性脑缺血再灌注损伤后炎症反应的影响。
This drug is an angiotensin converting enzyme inhibitor.
本品是一种血管紧张素转换酶抑制剂。
To produce fermented milk that can inhibit the activity of angiotensin converting enzyme(ACE), then the angiotensin converting enzyme inhibitor(ACEI) can be purified from the fermented milk.
用瑞士乳杆菌生产具有抑制血管紧张素转换酶（ACE）活性的发酵乳并从其中分离血管紧张素转换酶抑制剂（ACEI）。
Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.
目的研究血管紧张素转换酶抑制剂(acei)和血管紧张素受体拮抗剂(arb)对2型糖尿病肾病患者肾功能的保护作用。
Less than one-third of subjects were receiving an angiotensin converting enzyme inhibitor at baseline, although this rose to around 40% by the end of follow-up.
小于三分之一患者基线时接受了转换酶抑制剂治疗，但随访结束时，使用比例已上升至近40%。
Angiotensin converting enzyme inhibitor may increase the sensitivity of tissue to intrinsic and extrinsic insulin.
血管紧张肽转换酶抑制药可增加组织对内源性和外源性胰岛素的敏感性。
Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.
目的观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。
After the therapy with angiotensin converting enzyme inhibitor (ACEI), the endothelium-dependent vasodilation function was improved in the coronary groups and especially for the DD group.
血管紧张素转换酶抑制剂(acei)治疗后冠心病组各型肱动脉内皮依赖性舒张功能与治疗前比较均有显著性改善，其中DD基因型改善最为明显。
Conclusion it is suggested that perindopril should be the first choice when angiotensin converting enzyme inhibitor (ACEI) is taken into account for the therapy of primary hypertension.
结论应用血管紧张素转换酶抑制剂(acei)治疗原发性高血压时，宜首选培哚普利。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
应用推荐